Kainate-induced calcium overload of cortical neurons in vitro: Dependence on expression of AMPAR GluA2-subunit and down-regulation by subnanomolar ouabain

Cell Calcium

Volumn 54, Issue 2, 2013, Pages 95-104

  Abushik, Polina A ^a,c   Sibarov, Dmitry A ^a,c   Eaton, Misty J ^b   Skatchkov, Serguei N ^b   Antonov, Sergei M ^a,c  

^a SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

^b Universidad Central del Caribe School of Medicine   (Puerto Rico)

^c PETER THE GREAT ST PETERSBURG POLYTECHNIC UNIVERSITY   (Russian Federation)

Author keywords

Calcium; Cortical neurons; Excitotoxicity; Glutamate receptors; Ouabain; Subunit selective antagonists; Whole cell currents

Indexed keywords

1 (1 ADAMANTYLMETHYLAMMONIO) 5 TRIMETHYLAMMONIOPENTANE DIBROMIDE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID RECEPTOR GLUA2 SUBUNIT; CALCIUM; CALCIUM ION; IFENPRODIL; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; OUABAIN; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; FETUS; IN VITRO STUDY; INTERNEURON; INTRACELLULAR SIGNALING; MOLECULAR IMAGING; NEUROPROTECTION; NONHUMAN; PATCH CLAMP; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT;

RATTUS; STROPHANTHUS GRATUS;

EID: 84880506077     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2013.05.002     Document Type: Article

References (64)

1. Traynelis S.F., Wollmuth L.P., McBain C.J., et al. Glutamate receptor ion channels: structure, regulation and function. Pharmacological Reviews 2010, 62:405-496.
2. Choi D.W. Excitotoxic cell death. Journal of Neurobiology 1992, 23:1261-1276.
3. Olney J.W. Excitatory transmitter neurotoxicity. Neurobiology of Aging 1994, 15:259-260.
4. 2+ overload and neuronal apoptosis in excitotoxic stress. Journal of Pharmacology and Experimental Therapeutics 2012, 343:596-607.
5. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1:623-634.
6. Meldrum B. Amino acids as dietary excitotoxins: a contribution to understanding neurodegenerative disorders. Brain Research 1993, 18:293-314.
7. Lipton S.A. Ischemic cell death in brain neurons. Physiological Reviews 1999, 79:1431-1537.
8. Parsons C.G., Danysz W., Quack G. Glutamate in CNS disorders as a target for drug development: an update. Drug News and Perspectives 1998, 11:523-569.
9. Khodorov B. Glutamate-induced deregulation of calcium homeostasis and mitochondrial dysfunction in mammalian central neurons. Progress in Biophysics and Molecular biology 2004, 86:279-351.
10. Antonov S.M., Magazanik L.G. Intense nonquantal release of glutamate in an insect neuromuscular junction. Neuroscience Letters 1988, 93:204-208.
11. Szatkowski M., Barbour B., Attwell D. Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature 1990, 348:443-446.
12. Rossi D.J., Oshima T., Attwell D. Glutamate release in sever brain ischemia is mainly by reversed uptake. Nature 2000, 403:316-325.
13. Ascher P., Nowak L. The role of divalent cations in the N-methyl-d-aspartate responses of mouse central neurones in culture. Journal of Physiology 1988, 399:247-266.
14. Burnashev N., Zhou Z., Neher E., Sakmann B. Fractional calcium currents through recombinant GluR channels of the NMDA, AMPA and kainite receptor subtypes. Journal of Physiology 1995, 485:403-418.
15. MacDermott A.B., Mayer M.L., Westbrook G.L., Smith S.J., Barker J.L. NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons. Nature 1986, 321:519-522.
16. Dubinsky J.M., Rothman S.M. Intracellular calcium concentration during "chemical hypoxia" and excitotoxic neuronal injury. Journal of Neuroscience 1991, 11:2545-2551.
17. Nicholls D.G. Mitochondrial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures. Current Molecular Medicine 2004, 4:149-177.
18. Kiskin N.I., Krishtal O.A., Tsyndrenko A.Ya. Excitatory amino acid receptors in hippocampal neurons: kainate fails to desensitize them. Neuroscience Letters 1986, 63:225-230.
19. Patneau D.K., Mayer M.L. Kinetic analysis of interactions between kainite and AMPA: evidence for activation of a single receptor in mouse hippocampal neurons. Neuron 1991, 6:785-798.
20. Garthwaite J., Garthwaite G. The mechanism of kainic acid neurotoxicity. Nature 1983, 305:138-140.
21. Burnashev N., Monyer H., Seeburg P.H., Sakmann B. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 1992, 8:189-198.
22. Magazanik L.G., Buldakova S.L., Samoilova M.V., Gmiro V.E., Mellor I.R., Usherwood P.N. Block of open channels of recombinant AMPA receptors and native AMPA/kainite receptors by adamantine derivatives. Journal of Physiology 1997, 505:655-663.
23. 2+ transients in cultured spinal motor neurons. Cell Calcium 2007, 42:59-69.
24. Brunet N., Tarabal O., Esquerda J.E., Caldero J. Excitotoxic motoneuron degeneration induced by glutamate receptor agonists and mitochondrial toxins in organotypic cultures of chick embryo spinal cord. Journal of Comparative Neurology 2009, 516:277-290.
25. Williams K. Ifenprodil discriminates subtypes of the N-methyl-d-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Molecular Pharmacology 1993, 44:851-859.
26. Whittemore E.R., Ilyin V.I., Woodward R.M. Antagonism of N-methyl-d-aspartate receptors by sigma sute ligands: potency, subtype-selectivity and mechanisms of inhibition. Journal of Pharmacology and Experimental Therapeutics 1997, 282:326-338.
27. Antonov S.M., Johnson J.W., Lukomskaya N.Y., Potapyeva N.N., Gmiro V.E., Magazanik L.G. Novel adamantane derivatives act as blockers of open ligand-gated channels and as anticonvulsants. Molecular Pharmacology 1995, 47:558-567.
28. Han E.B., Stevens C.F. Development regulates a switch between post- and presynaptic strengthening in response to activity deprivation. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:10817-10822.
29. 2+of NMDA responses in spinal cord neurons. Nature 1984, 309:261-263.
30. Nowak L., Bregestovski P., Ascher P., Herbet A., Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurons. Nature 1984, 307:462-465.
31. Johnson J.W., Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987, 325:529-531.
32. 2+ deregulation in young cerebellar granule cells induced by overstimulation of glutamate receptors. Role of NMDA channels. Biological Membranes 2006, 23:311-319.
33. 2+ exchanger in excitotoxicity. Cell 2005, 120:275-285.
34. Zhong J., Rassell S.L., Pritchett D.B., Molinoff P.B., Williams K. Expression of mRNA encoding subunits of the N-methyl-d-aspartate receptor in cultured cortical neurons. Molecular Pharmacology 1994, 45:846-853.
35. Lopatin A.N., Makhina E.N., Nichols C.G. Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification. Nature 1994, 372:366-369.
36. Kucheryavykh Y.V., Shuba Y.M., Antonov S.M., et al. Complex rectification of Müller cell Kir currents. Glia 2008, 56:775-790.
37. Williams K. Interactions of polyamines with ion channels. Biochemical Journal 1997, 325:289-297.
38. 2+-permeable AMPA receptors in rat brain by intracellular polyamines generates double rectification. Journal of Physiology 1995, 486:305-312.
39. Huettner J.E. Kainate receptors and synaptic transmission. Progress in Neurobiology 2003, 70:387-407.
40. Pinheiro P.S., Mulle C. Presynaptic glutamate receptors: physiological function and mechanisms of action. Nature Reviews Neuroscience 2008, 9:423-436.
41. Bahn S., Volk B., Wisden W. Kainate receptor gene expression in the developing rat brain. Journal of Neuroscience 1994, 14:5525-5547.
42. Lerma J., Paternain A.V., Naranjo J.R., Mellstrom B. Functional kainate-selective glutamate receptors in cultured hippocampal neurons. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:11688-11692.
43. Jones K.A., Wilding T.J., Huettner J.E., Costa A.M. Desensitization of kainate receptors by kainate, glutamate and diastereomers of 4-methylglutamate. Neuropharmacology 1997, 36:853-863.
44. Paternain A.V., Rodriguez-Moreno A., Villarroel A., Lerma J. Activation and desensitization properties of native and recombinant kainate receptors. Neuropharmacology 1998, 37:1249-1259.
45. Wenthold R.J., Prybylowski K., Standley S., Sans N., Petralia R.S. Trafficking of NMDA receptors. Annual Review of Pharmacology and Toxicology 2003, 43:335-358.
46. Bowie D., Mayer M.L. Inward rectification of both AMPA and kainite subtype glutamate receptors generated by polyamine-mediated ion channel block. Neuron 1995, 15:453-462.
47. Panchenko V.A., Glasser C.R., Partin K.M., Mayer M.L. Amino acid substitutions in the pore of rat glutamate receptors at sites influencing block by polyamines. Journal of Physiology 1999, 520:337-357.
48. Rozov A., Burnashev N. Polyamine-dependent facilitation of postsynaptic AMPA receptors counteracts paired-pulse depression. Nature 1999, 401:594-598.
49. Isaac J.T., Ashby M., McBain C.J. The role of the GluR2 subunit in AMPA receptor function and synaptic plasticity. Neuron 2007, 54:859-871.
50. Herlitze S., Raditsch M., Ruppersberg J.P., Jahn W., Monyer H., Schoepfer R., Witzemann V. Argiotoxin detects molecular differences in AMPA receptor channels. Neuron 1996, 10:1131-1140.
51. Grishin E.V., Volkova T.M., Arsen'ev A.S., et al. Structural-functional characteristics of argiopine - the ion channel blockers from the spider Argiope lobata venom. Bioorganicheskaia Khimiia 1986, 12:1121-1124.
52. Budd T., Clinton P., Dell A., et al. Isolation and characterization of glutamate receptor antagonists from venoms of orb-web spiders. Brain Research 1988, 448:30-39.
53. Jackson H., Usherwood P.N. Spider toxins as tools for dissecting elements of excitatory amino acid transmission. Trends in Neurosciences 1988, 11:278-283.
54. Antonov S.M., Dudel J., Franke C., Hatt H. Argiopine blocks glutamate-activated single-channel currents on crayfish muscles by two mechanisms. Journal of Physiology 1989, 419:569-587.
55. Antonov S.M., Gmiro V.E., Johnson J.W. Binding sites for permeant ions in the channel of NMDA receptors and their effects on channel block. Nature Neuroscience 1998, 1:451-461.
56. Bähring R., Mayer M.L. An analysis of philanthotoxin block for recombinant rat GluR6(Q) glutamate receptor channels. Journal of Physiology 1998, 509:635-650.
57. Ashby M.C., Daw M.I., Isaac J.T.R. AMPA receptors. The Glutamate Receptors 2008, 1-44. Humana Press, Totowa, NJ. R.W. Gereau, G.T. Swanson (Eds.).
58. Antonov S.M., Kalinina N.I., Kurchavyj G.G., Magazanik L.G., Shupliakov O.V., Vesselkin N.P. Identification of two types of excitatory monosynaptic inputs in frog spinal motoneurons. Neuroscience Letters 1990, 109:82-87.
59. Dobretsov M., Stimers J.R. Neuronal function and alpha3 isoform of the Na/K-ATPase. Frontiers in Bioscience 2005, 10:2373-2396.
60. Golden W.C., Martin L.J. Low-dose ouabain protects against excitotoxic apoptosis and up-regulates nuclear BCL-2 in vivo. Neuroscience 2006, 137:133-144.
61. Li J., Khodus G.R., Kruusmägi M., et al. Ouabain protects against adverse developmental programming of the kidney. Nature Communications 2010, 1:1-7.
62. Pasdois P., Quinlan C.L., Rissa A., et al. Ouabain protects rat hearts against ischemia-reperfusion injury via pathway involving src kinase, mitoKATP, and ROS. American Journal of Physiology: Heart and Circulatory Physiology 2007, 292:H1470-H1478.
63. Krivoi I.I., Drabkina T.M., Kravtsova V.V., et al. On the functional interaction between nicotinic acetylcholine receptor and Na+, K+ -ATPase. Pflugers Archiv 2006, 452:756-765.
64. Chibalin A.V., Heiny J.A., Benziane B., et al. Chronic nicotine modifies skeletal muscle Na, K-ATPase activity through its interaction with the nicotinic acetylcholine receptor and phospholemman. PLoS One 2012, 7:e33719.